Coya Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $4.65-$10.24 |
Market Cap | $95.3M |
Shares Short | 260,138 |
Financials
See moreRevenue (12 Mos) | $423,452 |
Revenue Growth (YoY) | -95.2% |
Gross Profit (12 Mos) | -$12.6M |
Diluted EPS | -$1.29 |
News
See moreYahoo Finance • 25 days ago
Biotech Stocks Surge After Hours: CAPR, TMDX Lead Gains Amid Trial Updates And Earnings Momentum
Yahoo Finance • 30 days ago
PRISM MarketView Features Exclusive Q&A with Coya Therapeutics CEO Arun Swaminathan on Targeting Neurodegenerative Diseases Through Treg Therapies
Yahoo Finance • 2 months ago
Coya Therapeutics GAAP EPS of -$0.36
Yahoo Finance • 3 months ago
Coya Therapeutics resubmits IND application for ALS Phase 2 study to FDA
About
CEO | Dr. Arun Swaminathan Ph.D. |
CFO | Mr. David S. Snyder |
Address | 5850 San Felipe St., Houston, TX, United States, 77057 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 8 |
